• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左脑梗死患者生物瓣膜退变伴明显赘生物的再次经导管主动脉瓣置换术

Redo-TAVR for bioprosthetic valve degeneration with obvious neoplasm in a left cerebral infarction patient.

作者信息

Liu Weili, Li Dacheng, Qu Zhanjun, Tang Guozhang, Liu Song, Li Yanchao, Jiang Lei

机构信息

Interventional Operation Room Affiliated Hospital of Qingdao University Qingdao China.

Department of Nuclear Medicine Affiliated Hospital of Qingdao University Qingdao China.

出版信息

Clin Case Rep. 2024 Aug 7;12(8):e9315. doi: 10.1002/ccr3.9315. eCollection 2024 Aug.

DOI:10.1002/ccr3.9315
PMID:39119032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11305981/
Abstract

KEY CLINICAL MESSAGE

In recent years, it is necessary to Redo-TAVR for the patients with bioprosthetic valve degeneration. This case report described a unique instance to successfully Redo-TAVR a patient with bioprosthetic valve degeneration, in addition, with left cerebral infarction and renal insufficiency.

ABSTRACT

Over time, more and more patients have bioprosthetic valve degeneration either used in SAVR or TAVR. In order to solve the produced problems due to the degenerated bioprosthetic valve, Redo-TAVR was increasingly popular due to its safe and efficiency especially for the high risk and complicated symptoms patients. In this case, the patient with left cerebral infarction and renal insufficiency has exhibited severe regurgitation and obvious neoplasm around the previous replaced aortic valve. For the patient with complicated symptoms, we did not image for this patient and only used CT to determine the position and angle for the Redo-TAVR on the base of metal stent for the previous replaced aortic valve. During the Redo-TAVR process, for fear of the obvious neoplasm slipping from the previous replaced aortic valve to embolism of important organs, before carrying out the Redo-TAVR, cerebral protection device, temporary pacemaker, and coronary artery protection device were utilized in order to avoid the damage for the important organs from the obvious neoplasm slipping from the previous replaced aortic valve. The surgery was successful and the patient recovered well. The patient's symptoms of chest tightness and suffocation have been greatly reduced.

摘要

关键临床信息

近年来,对于生物瓣退化的患者,再次经导管主动脉瓣置换术(Redo-TAVR)很有必要。本病例报告描述了一例成功为生物瓣退化患者进行再次经导管主动脉瓣置换术的独特案例,此外,该患者还伴有左脑梗死和肾功能不全。

摘要

随着时间的推移,越来越多接受外科主动脉瓣置换术(SAVR)或经导管主动脉瓣置换术(TAVR)的患者出现生物瓣退化。为了解决生物瓣退化所产生的问题,再次经导管主动脉瓣置换术因其安全性和有效性,在高危和症状复杂的患者中越来越受欢迎。在本病例中,患有左脑梗死和肾功能不全的患者,其先前置换的主动脉瓣周围出现了严重反流和明显赘生物。对于症状复杂的该患者,我们未对其进行造影成像,仅根据先前置换主动脉瓣的金属支架,使用计算机断层扫描(CT)来确定再次经导管主动脉瓣置换术的位置和角度。在再次经导管主动脉瓣置换术过程中,由于担心明显赘生物从先前置换的主动脉瓣上脱落导致重要器官栓塞,在进行再次经导管主动脉瓣置换术前,使用了脑保护装置、临时起搏器和冠状动脉保护装置,以避免明显赘生物从先前置换的主动脉瓣上脱落对重要器官造成损害。手术成功,患者恢复良好。患者胸闷、气促症状明显减轻。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5e/11305981/062c4fb7a12a/CCR3-12-e9315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5e/11305981/2e705f0bee68/CCR3-12-e9315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5e/11305981/cebbb348ed40/CCR3-12-e9315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5e/11305981/062c4fb7a12a/CCR3-12-e9315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5e/11305981/2e705f0bee68/CCR3-12-e9315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5e/11305981/cebbb348ed40/CCR3-12-e9315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5e/11305981/062c4fb7a12a/CCR3-12-e9315-g002.jpg

相似文献

1
Redo-TAVR for bioprosthetic valve degeneration with obvious neoplasm in a left cerebral infarction patient.左脑梗死患者生物瓣膜退变伴明显赘生物的再次经导管主动脉瓣置换术
Clin Case Rep. 2024 Aug 7;12(8):e9315. doi: 10.1002/ccr3.9315. eCollection 2024 Aug.
2
Valve-in-valve transcatheter aortic valve replacement versus redo surgical valve replacement for degenerated bioprosthetic aortic valve: An updated meta-analysis comparing midterm outcomes.经导管主动脉瓣置换术治疗退行性生物瓣主动脉瓣与再次开胸换瓣术治疗退行性生物瓣主动脉瓣的对比:一项比较中期结果的更新荟萃分析。
Catheter Cardiovasc Interv. 2021 Jun 1;97(7):1481-1488. doi: 10.1002/ccd.29541. Epub 2021 Feb 13.
3
Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.比较生物人工主动脉瓣退变患者行瓣中瓣经导管主动脉瓣置换术和再次外科主动脉瓣置换术的荟萃分析。
Catheter Cardiovasc Interv. 2021 Nov 1;98(5):940-947. doi: 10.1002/ccd.29789. Epub 2021 Jun 10.
4
Valve-in-valve transcatheter aortic valve replacement versus redo aortic valve replacement: which procedure for which patient?经导管主动脉瓣置换术中瓣中瓣技术与再次主动脉瓣置换术:哪种术式适用于哪种患者?
Expert Rev Cardiovasc Ther. 2022 Dec;20(12):911-918. doi: 10.1080/14779072.2022.2153118. Epub 2022 Dec 5.
5
Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves.经导管或外科手术置换生物瓣衰败的主动脉瓣。
JAMA Cardiol. 2024 Jul 1;9(7):631-639. doi: 10.1001/jamacardio.2024.1049.
6
Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.再次经导管主动脉瓣置换术治疗术后及晚期发生的瓣周反流和经导管瓣膜功能障碍的结果
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.116.003930.
7
Aortic Regurgitation, Time to Aortic Valve Reintervention, and Mortality in Degenerated Trifecta Versus Non-Trifecta Bioprosthesis.退行性三尖瓣生物瓣与非三尖瓣生物瓣的主动脉瓣反流、主动脉瓣再次干预时间及死亡率
Am J Cardiol. 2024 Jun 1;220:49-55. doi: 10.1016/j.amjcard.2024.03.033. Epub 2024 Apr 4.
8
What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement?对于主动脉生物人工瓣膜功能失效的患者,最佳治疗方法是什么:经导管主动脉瓣置换术还是再次主动脉瓣置换术?
Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):837-43. doi: 10.1093/icvts/ivv037. Epub 2015 Mar 8.
9
Early Acurate Neo transcatheter heart valve degeneration in a haemodialysis patient successfully managed with Sapien 3 Ultra: a case report.血液透析患者早期准确的新型经导管心脏瓣膜退变经Sapien 3 Ultra成功治疗:一例报告
Eur Heart J Case Rep. 2022 Jul 1;6(7):ytac279. doi: 10.1093/ehjcr/ytac279. eCollection 2022 Jul.
10
Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: A systematic review and meta-analysis.经导管主动脉瓣置换术中瓣中瓣技术与再次开胸主动脉瓣置换术的比较:一项系统评价和荟萃分析。
J Card Surg. 2021 Jul;36(7):2486-2495. doi: 10.1111/jocs.15546. Epub 2021 Apr 2.

本文引用的文献

1
Risk of Coronary Obstruction During Redo-TAVR in Patients With Bicuspid Versus Tricuspid Aortic Valve Stenosis.二叶式主动脉瓣与三叶式主动脉瓣狭窄患者再次行经导管主动脉瓣置换术时发生冠状动脉阻塞的风险。
JACC Cardiovasc Interv. 2022 Apr 11;15(7):712-724. doi: 10.1016/j.jcin.2022.01.282.
2
Cerebral Protection in TAVR-Can We Do Without? A Real-World All-Comer Intention-to-Treat Study-Impact on Stroke Rate, Length of Hospital Stay, and Twelve-Month Mortality.经导管主动脉瓣置换术中的脑保护——我们能否不用?一项真实世界的全人群意向性治疗研究——对卒中发生率、住院时间和12个月死亡率的影响
J Pers Med. 2022 Feb 21;12(2):320. doi: 10.3390/jpm12020320.
3
Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
比较生物人工主动脉瓣退变患者行瓣中瓣经导管主动脉瓣置换术和再次外科主动脉瓣置换术的荟萃分析。
Catheter Cardiovasc Interv. 2021 Nov 1;98(5):940-947. doi: 10.1002/ccd.29789. Epub 2021 Jun 10.
4
Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry.经导管主动脉瓣置换术期间预防冠状动脉阻塞的冠状动脉保护:多中心国际注册研究。
JACC Cardiovasc Interv. 2020 Mar 23;13(6):739-747. doi: 10.1016/j.jcin.2019.11.024. Epub 2020 Feb 12.
5
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: From Computed Tomography to BASILICA.经导管主动脉瓣置换术中预防冠状动脉阻塞:从计算机断层扫描到 BASILICA。
JACC Cardiovasc Interv. 2019 Jul 8;12(13):1197-1216. doi: 10.1016/j.jcin.2019.04.052.
6
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.经皮球囊扩张式主动脉瓣置换术治疗低危患者。
N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.
7
The "Big Five" Complications After Transcatheter Aortic Valve Replacement: Do We Still Have to Be Afraid of Them?经导管主动脉瓣置换术后的“五大”并发症:我们还需要惧怕它们吗?
JACC Cardiovasc Interv. 2019 Feb 25;12(4):370-372. doi: 10.1016/j.jcin.2018.12.019.
8
Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.经导管主动脉瓣置换术中使用脑保护装置时观察到的围手术期卒中发生率:一项基于患者倾向评分匹配的分析。
Eur Heart J. 2019 May 1;40(17):1334-1340. doi: 10.1093/eurheartj/ehy847.
9
Acute Kidney Injury After Transcatheter Aortic Valve Replacement.
Circ Cardiovasc Interv. 2018 Aug;11(8):e007135. doi: 10.1161/CIRCINTERVENTIONS.118.007135.
10
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.